Pulmonary Embolism and PCSK9 Inhibitors: Case Discussion

Hi Renukaprasad A R, Pulmonary embolism (PE) is the third most common cause of cardiovascular death and accounts for almost 100,000 deaths annually in India. PCSK9 class of inhibitors can effectively prevent the formation of emboli as well as its associated cardiovascular .complications if used appropriately. Join expert cardiologists Dr. Hemang Baxi and Dr. Tejas V. Patel to discuss "A Case-based Discussion on Pulmonary Embolism and use of PCSK-9-Inhibitors" TODAY, 3:00 PM IST onwards. Click to Join   India's Largest Online Community Of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*